The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma

Annals of Oncology

Volumn 17, Issue 10, 2006, Pages 1539-1545

  Gine E ^a   Montoto, S ^a   Bosch, F ^a   Arenillas, L ^a   Mercadal, S ^a   Villamor, N ^a   Martinez A ^a   Colomo, L ^a   Campo, E ^a   Montserrat, E ^a   Lopez Guillermo A ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

FLIPI; Follicular lymphoma; Transformation

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; BETA 2 MICROGLOBULIN; CHLORAMBUCIL; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; IFOSFAMIDE; LACTATE DEHYDROGENASE; METHOTREXATE; MITOXANTRONE; PREDNISONE; VINCRISTINE; VINCRISTINE SULFATE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; B CELL LYMPHOMA; CANCER INCIDENCE; CANCER PATIENT; CANCER RISK; CANCER SURVIVAL; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; FOLLICULAR LYMPHOMA; FOLLOW UP; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; LYMPHOCYTE TRANSFORMATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; SALVAGE THERAPY; SEX DIFFERENCE; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; FEMALE; HEALTH STATUS INDICATORS; HUMANS; INCIDENCE; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 33749632375     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdl162     Document Type: Article

References (36)

1. Hubbard SM, Chabner BA, DeVita VT et al. Histologic progression in non-Hodgkin's lymphoma. Blood 1982; 59(2): 258-264.
2. Oviatt DL, Cousar JB, Collins RD et al. Malignant lymphomas of follicular center cell origin in humans. V. Incidence, clinical features, and prognostic implications of transformation of small cleaved cell nodular lymphoma. Cancer 1984; 53(5): 1109-1114.
3. Bastion Y, Sebban C, Berger F et al. Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients. J Clin Oncol 1997; 15(4): 1587-1594.
4. Nagy M, Balazs M, Adam Z et al. Genetic instability is associated with histological transformation of follicle center lymphoma. Leukemia 2000; 14(12): 2142-2148.
5. Yunis JJ, Frizzera G, Oken MM et al. Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer. N Engl J Med 1987; 316(2): 79-84.
6. Richardson ME, Chen QG, Filippa DA et al. Intermediate- to high-grade histology of lymphomas carrying t(14; 18) is associated with additional nonrandom chromosome changes. Blood 1987; 70(2): 444-447.
7. Armitage JO, Sanger WG, Weisenburger DD et al. Correlation of secondary cytogenetic abnormalities with histologic appearance in non-Hodgkin's lymphomas bearing t(14; 18) (q32; q21). J Natl Cancer Inst 1988; 80(8): 576-580.
8. Yano T, Jaffe ES, Longo DL, Raffeld M. MYC rearrangements in histologically progressed follicular lymphomas. Blood 1992; 80(3): 758-767.
9. Sander CA, Yano T, Clark HM et al. p53 mutation is associated with progression in follicular lymphomas. Blood 1993; 82(7): 1994-2004.
10. Davies AJ, Lee AM, Taylor C et al. A limited role for TP53 mutation in the transformation of follicular lymphoma to diffuse large B-cell lymphoma. Leukemia 2005; 19(8): 1459-1465.
11. Pinyol M, Cobo F, Bea S et al. p16 (INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas. Blood 1998; 91(8): 2977-2984.
12. Elenitoba-Johnson KS, Gascoyne RD, Lim MS et al. Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma. Blood 1998; 91(12): 4677-4685.
13. Akasaka T, Lossos IS, Levy R. BCL6 gene translocation in follicular lymphoma: A harbinger of eventual transformation to diffuse aggressive lymphoma. Blood 2003; 102(4): 1443-1448.
14. Yuen AR, Kamel OW, Halpern J, Horning SJ. Long-term survival after histologic transformation of low-grade follicular lymphoma. J Clin Oncol 1995; 13(7): 1726-1733.
15. Cohen Y, Da'as N, Libster D et al. Large-cell transformation of chronic lymphocytic leukemia and follicular lymphoma during or soon after treatment with fludarabine-rituximab-containing regimens: Natural history- or therapy-related complication? Eur J Haematol 2002; 68(2): 80-83.
16. Lerner RE, Burns LJ. Transformed lymphoma: An Achilles' heel of non-Hodgkin's lymphoma. Bone Marrow Transplant 2003; 31(7): 531-537.
17. Lossos IS. Higher-grade transformation of follicular lymphoma - a continuous enigma. Leukemia 2005; 19(8): 1331-1333.
18. Risdall R, Hoppe RT, Warnke R. Non-Hodgkin's lymphoma: A study of the evolution of the disease based upon 92 autopsied cases. Cancer 1979; 44(2): 529-542.
19. Garvin AJ, Simon RM, Osborne CK et al. An autopsy study of histologic progression in non-Hodgkin's lymphomas. 192 cases from the National Cancer Institute. Cancer 1983; 52(3): 393-398.
20. Gine E, Lopez-Guillermo A, Montoto S et al. FLIPI and histological subtype are the most important predicting factors of histological transformation in follicular lymphoma. Ann Oncol 2005; 16: 106a (Abstr.).
21. Montoto S, Davies AJ, Matthews J et al. Risk and clinical implications of transformation of follicular lymphoma (FL) to diffuse large cell B-cell lymphoma (tFL). Blood 2005; 106: 602a (Abstr.).
22. Foran JM, Apostolidis J, Papamichael D et al. High-dose therapy with autologous haematopoietic support in patients with transformed follicular lymphoma: A study of 27 patients from a single centre. Ann Oncol 1998; 9(8): 865-869.
23. Williams CD, Harrison CN, Lister TA et al. European Bone Marrow Transplant Lymphoma Working Party. High-dose therapy and autologous stem-cell support for chemosensitive transformed low-grade follicular non-Hodgkin's lymphoma: A case-matched study from the European Bone Marrow Transplant Registry. J Clin Oncol 2001; 19(3): 727-735.
24. Chen CI, Crump M, Tsang R et al. Autotransplants for histologically transformed follicular non-Hodgkin's lymphoma. Br J Haematol 2001; 113(1): 202-208.
25. Berglund A, Enblad G, Carlson K et al. Long-term follow-up of autologous stem-cell transplantation for follicular and transformed follicular lymphoma. Eur J Haematol 2000; 65(1): 17-22.
26. Harris NL, Jaffe ES, Diebold J et al. The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Mod Pathol 2000; 13(2): 193-207.
27. Montoto S, Lopez-Guillermo A, Ferrer A et al. Survival after progression in patients with follicular lymphoma: Analysis of prognostic factors. Ann Oncol 2002; 13(4): 523-530.
28. Montoto S, Lopez-Guillermo A, Altes A et al. Predictive value of Follicular Lymphoma International Prognostic Index (FLIPI) in patients with follicular lymphoma at first progression. Ann Oncol 2004; 15(10): 1484-1489.
29. Solal-Celigny P, Roy P, Colombat P et al. Follicular lymphoma international prognostic index. Blood 2004; 104(5): 1258-1265.
30. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993; 329(14): 987-994.
31. Federico M, Vitolo U, Zinzani PL et al. Prognosis of follicular lymphoma: A predictive model based on a retrospective analysis of 987 cases. Intergruppo Italiano Linfomi. Blood 2000; 95(3): 783-789.
32. Cheson BD, Horning SJ, Coiffier B et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999; 17(4): 1244. (Erratum in: J Clin Oncol 2000; 18(11): 2351.)
33. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
34. Peto R, Pike MC. Conservatism of the approximation sigma (O-E)2-E in the log-rank test for survival data or tumor incidence data. Biometrics 1973; 29(3): 579-584.
35. Cox DR. Regression models and life tables. J Roy Stat Assoc 1972; 34: 187-220.
36. Al-tourah A, Chhanabhai M, Gill K et al. Incidence, predictive factors and outcome of transformed lymphoma: A population-based study from British Columbia. Ann Oncol 2005; 16: 64a (Abstr.).